Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
NEWARK, CA / ACCESSWIRE / August 1, 2024 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced publication of preclinical and phase 1 clinical data on JNJ-2113 in the journ
NEWARK, CA / ACCESSWIRE / August 1, 2024 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced publication of preclinical and phase 1 clinical data on JNJ-2113 in the journ
7 Leading MedTech Stocks for Next-Gen Health Solutions
02:30pm, Wednesday, 31'st Jul 2024
While technology lately has been framed in the context of computer hardware or software, it can also apply to the broader field of medicine. Therefore, investors should consider the viable field of Me
Findings from first-ever quadruplet therapy study with subcutaneous DARZALEX FASPRO® showed 60 percent reduction in risk of disease progression or death New regimen solidifies DARZALEX FASPRO ® as
Q3's Rising Stars: 3 Dow Stocks for Your Must-Watch List
12:35pm, Tuesday, 30'th Jul 2024
The Dow Jones Industrial Average is a laggard in 2024. While other indices roared higher over the first half of the year, the venerable Dow gained only about half of its peers.
Top 2 Cheap Healthcare Stocks to Buy as Sector Outperforms
07:08am, Tuesday, 30'th Jul 2024
As the second half of the year has gotten underway, the healthcare sector, represented by the XLV ETF, has seen a notable resurgence. This sector, which had been underperforming since the pandemic, is
Pharma companies less concerned after hearing from US on negotiated prices for Medicare
01:37pm, Monday, 29'th Jul 2024
Four pharmaceutical companies involved in the first U.S. negotiations over prices for the Medicare program said they do not expect a significant impact on their businesses after seeing confidential su
Could Johnson & Johnson's Troubles With Talc Lawsuits Finally Be Coming to an End?
06:35am, Saturday, 27'th Jul 2024
Johnson & Johnson is attempting to resolve talc lawsuits through bankruptcy for a third time. This time around, it's letting claimants vote on its proposed settlement.
Top 10 Dividend Stocks For A Recession-Focused Portfolio In 2024
02:00pm, Friday, 26'th Jul 2024
Preparing for a recession and the next stock market decline is important as it can help you to significantly reduce the volatility of your investment portfolio. In this article, I have selected 10 com
FINAL DEADLINE: Ovarian Cancer Victims Have Until 5pm ET Today to Vote on Approximately $8 Billion J&J Talc Compensation Plan
09:05am, Friday, 26'th Jul 2024
NEW YORK--(BUSINESS WIRE)--Today at 5pm ET is the final deadline for tens of thousands of ovarian cancer victims or their representatives to vote on the approximately $8 billion Johnson & Johnson (“
If approved, Yuvanci® would become the only single tablet combination for treatment for patients with PAH Johnson & Johnson's comprehensive PAH portfolio has the potential to cover all guideline-reco
How Should You Play J&J (JNJ) Stock After Q2 Earnings Beat?
12:05pm, Thursday, 25'th Jul 2024
Though J&J (JNJ) beat estimates for both earnings and sales in the second quarter, a new investor should avoid buying the stock right now due to its legal troubles.
3 Beaten-Down Value Stocks Poised for a Massive Comeback: July 2024
07:45am, Thursday, 25'th Jul 2024
There are deals to be found in the current market. If the goal is to buy low and sell high, then investors should find lots to like among value and blue-chip stocks that have been beaten down and whos
Grab These 5 Overlooked Dividend Aristocrats Before Wall Street Catches On
10:12am, Wednesday, 24'th Jul 2024
24/7 Insights The Dividend Aristocrats provide dependable passive income streams.
Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
10:01am, Wednesday, 24'th Jul 2024
Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
